First Allied Advisory Services’s Immunomedics Inc IMMU Stock Holding History

First Allied Advisory Services’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$272K	Sell	3,200 -2,942	-48%	-$149K	0.01%	937
2020 Q2	$218K	Buy	+6,142	New	+$180K	0.01%	964
2018 Q4	–	Sell	-9,900	Closed	-$206K	–	1225
2018 Q3	$206K	Buy	9,900 +1,300	+15%	+$30.8K	0.01%	1067
2018 Q2	$205K	Buy	+8,600	New	+$173K	0.01%	1047

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

First Allied Advisory Services's IMMU Position: Q3 2020 in Review

First Allied Advisory Services reduced its Immunomedics Inc (IMMU) stake by 48% in Q3 2020, selling an estimated $149K and leaving 3,200 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #937.

First Allied Advisory Services first reported a position in IMMU in Q2 2018 and has held it in 4 quarters since. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

First Allied Advisory Services held 3,200 shares of Immunomedics Inc worth $272K as of Q3 2020.
First Allied Advisory Services sold 2,942 Immunomedics Inc shares in Q3 2020, an estimated $149K.
Immunomedics Inc made up 0.01% of First Allied Advisory Services's portfolio in Q3 2020, its #937 holding.
First Allied Advisory Services first reported a position in Immunomedics Inc in Q2 2018 and has held it in 4 quarters since.
408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.